Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1985-10-3
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0042-4668
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3875919-Adult,
pubmed-meshheading:3875919-Cochlea,
pubmed-meshheading:3875919-Female,
pubmed-meshheading:3875919-Humans,
pubmed-meshheading:3875919-Labyrinth Diseases,
pubmed-meshheading:3875919-Male,
pubmed-meshheading:3875919-Meniere Disease,
pubmed-meshheading:3875919-Middle Aged,
pubmed-meshheading:3875919-Tromethamine,
pubmed-meshheading:3875919-Vestibule, Labyrinth
|
pubmed:articleTitle |
[Use of trisamine for treating patients with cochleovestibular disorders].
|
pubmed:publicationType |
Journal Article
|